Related Experiment Videos

To statin or to non-statin in coronary disease--considering absolute risk is the answer

Christopher M Rembold1

  • 1Cardiovascular Division, Department of Internal Medicine, University of Virginia, Charlottesville, VA 22908, USA. crembold@virginia.edu

Atherosclerosis
|October 27, 2006
PubMed

Insights

For coronary artery disease (CAD), statins offer benefits, but non-statin therapies like niacin and gemfibrozil may provide greater risk reduction in certain patients. A Mediterranean diet also shows promise for cardiovascular health.

Area of Science:

  • Cardiovascular Medicine
  • Pharmacology
  • Preventive Cardiology

Background:

  • Current coronary artery disease (CAD) guidelines emphasize statin therapy for LDL cholesterol lowering, irrespective of baseline levels.
  • Recent trials demonstrate statistically significant relative risk reductions (RRR) in cardiovascular events with statins.
  • Established non-statin anti-atherosclerotic treatments exist but are less emphasized in recent guidelines.

Purpose of the Study:

  • To guide physicians in selecting optimal anti-atherosclerotic treatments based on individual patient benefit.
  • To compare the efficacy of statin and non-statin therapies using absolute risk reduction (ARR) analysis.
  • To evaluate treatment benefits across different CAD patient profiles, including stable and acute coronary syndrome (ACS) phases.

Main Methods:

  • Analysis of clinical trial data focusing on absolute risk reduction (ARR) to account for baseline cardiovascular risk.
  • Comparison of statin therapy versus non-statin agents (niacin, gemfibrozil) in patients with chronic CAD.
  • Evaluation of treatment effects in the first year post-acute coronary syndrome (ACS) and in chronic CAD.

Main Results:

  • Statin therapy showed significant benefit in stable CAD with high LDL cholesterol but diminishing returns at lower levels.
  • Niacin or gemfibrozil provided comparable or greater ARR than statins in chronic CAD patients with lower LDL cholesterol.
  • Mediterranean diet and statin therapy (targeting LDL ~80 mg/dL) demonstrated benefit in the first year post-ACS and in chronic CAD.

Conclusions:

  • Absolute risk reduction (ARR) is crucial for personalized treatment decisions in CAD management.
  • Non-statin therapies offer significant, potentially superior, benefits for specific patient groups with lower LDL cholesterol.
  • Both statin and non-statin therapies, alongside lifestyle interventions like the Mediterranean diet, are vital for managing atherosclerosis.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Relative Risk01:12

Relative Risk

Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...